In-vitro antitumor activity evaluation of hyperforin derivatives

Journal of Asian Natural Products Research

Volumn 13, Issue 8, 2011, Pages 688-699

  Sun, Feng ^a   Liu, Jin Yun ^a   He, Feng ^a   Liu, Zhong ^b   Wang, Rui ^b   Wang, Dong Mei ^a   Wang, Yi Fei ^b   Yang, De Po ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

Antiproliferative effect; Apoptosis; Hyperforin derivatives; Quantum chemistry calculation

Indexed keywords

17,18,22,23,27,28,32,33 OCTAHYDROHYPERFORIN ACETATE; HYPERFORIN; HYPERFORIN ACETATE; N,N DICYCLOHEXYLAMINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CHRONIC MYELOID LEUKEMIA; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MELANOMA; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HELA CELLS; HEP G2 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; K562 CELLS; MOLECULAR STRUCTURE; PHLOROGLUCINOL; TERPENES;

EID: 79960539676     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020.2011.584532     Document Type: Article

References (23)

1. S. S. Chatterjee, S. K. Bhattacharya, M. Wonnemann, A. Singer, and W. E. Müller, Life Sci. 63, 499 (1998).
2. W. E. Muller, A. Singer, M. Wonnemann, U. Hafner, M. Rolli, and C. Schafer, Pharmacopsychiatry 31, 16 (1998).
3. A. Singer, M. Wonnemann, and W. E. Müller, J. Pharmacol. Exp. Ther. 290, 1363 (1999).
4. P. Avato, F. Raffo, G. Guglielmi, C. Vitali, and A. Rosato, Phytother. Res. 18, 230 (2004).
5. C. Cecchini, A. Cresci, M. M. Coman, M. Ricciutelli, G. Sagratini, S. Vittori, D. Lucarini, and F. Maggi, Planta Med. 73, 564 (2007).
6. K. D. P. Hammer, M. L. Hillwig, A. K. S. Solco, P. M. Dixon, K. Delate, P. A. Murphy, E. S. Wurtele, and D. F. Birt, J. Agric. Food Chem. 55, 7323 (2007).
7. C. Feisst, C. Pergola, M. Rakonjac, A. Rossi, A. Koeberle, G. Dodt, M. Hoffmann, C. Hoernig, L. Fischer, D. Steinhilber, L. Franke, G. Schneider, O. Radmark, L. Sautebin, and O. Werz, Cell. Mol. Life Sci. 66, 2759 (2009).
8. C. M. Schempp, V. Kirkin, B. Simon-Haarhaus, A. Kersten, J. Kiss, C. C. Termeer, B. Gilb, T. Kaufmann, C. Borner, J. P. Sleeman, and J. C. Simon, Oncogene 21, 1242 (2002).
9. C. Quiney, C. Billard, A. M. Faussat, C. Salanoubat, A. Ensaf, Y. Nait-Si, J. Fourneron, and J. P. Kolb, Leukemia 20, 491 (2006).
10. M. Rothley, A. Schmid, W. Thiele, V. Schacht, D. Plaumann, M. Gartner, A. Yektaoglu, F. Bruyere, A. Noel, A. Giannis, and J. P. Sleeman, Int. J. Cancer 125, 34 (2009).
11. K. Hostanska, J. Reichling, S. Bommer, M. Weber, and R. Saller, Eur. J. Pharm. Biopharm. 56, 121 (2003).
12. B. Martinez-Poveda, A. R. Quesada, and M. A. Medina, Int. J. Cancer 117, 775 (2005).
13. C. Quiney, C. Billard, P. Mirshahi, J. D. Fourneron, and J. P. Kolb, Leukemia 20, 583 (2006).
14. M. Dona, I. Dell'Aica, E. Pezzato, L. Sartor, F. Calabrese, M. Della Barbera, A. Donella-Deana, G. Appendino, A. Borsarini, R. Caniato, and S. Garbisa, Cancer Res. 64, 6225 (2004).
15. M. Gartner, T. Muller, J. C. Simon, A. Giannis, and J. P. Sleeman, Chembiochem 6, 171 (2005).
16. W. G. Richards, Quantum Pharmacology (Butterworths, London, 1983), p. 153.
17. B. P. Bandgar, S. S. Gawande, R. G. Bodade, J. V. Totre, and C. N. Khobragade, Bioorg. Med. Chem. 18, 1364 (2010).
18. A. K. Bhattacharjee, J. A. Gordon, E. Marek, A. Campbell, and R. K. Gordon, Bioorg. Med. Chem. 17, 3999 (2009).
19. L. Verotta, G. Appendino, E. Belloro, F. Bianchi, O. Sterner, M. Lovati, and E. Bombardelli, J. Nat. Prod. 65, 433 (2002).
20. E. Bombardelli, P. Marazzoni, A. Riva, N. WO 03091194 (A1) Fuzzati, (2003).
21. S. S. Chatterjee, C. Erdelmeier, K. Klessing, D. Marme, C. WO 9941220 Schachtele, (1999).
22. T. Mosmann, J. Immunol. Methods 65, 55 (1983).
23. M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, J. A. Montgomery, T. Vreven Jr, K. N. Kudin, J. C. Burant, J. M. Millam, S. S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G. A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J. E. Knox, H. P. Hratchian, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, P. Y. Ayala, K. Morokuma, G. A. Voth, P. Salvador, J. J. Dannenberg, V. G. Zakrzewski, S. Dapprich, A. D. Daniels, M. C. Strain, O. Farkas, D. K. Malick, A. D. Rabuck, K. Raghavachari, J. B. Foresman, J. V. Ortiz, Q. Cui, A. G. Baboul, S. Clifford, J. Cioslowski, B. B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. L. Martin, D. J. Fox, T. Keith, M. A. Al-Laham, C. Y. Peng, A. Nanayakkara, M. Challacombe, P. M. W. Gill, B. Johnson, W. Chen, M. W. Wong, C. Gonzalez, and J. A. Pople, Gaussian 03, Revision D.1 (Gaussian, Inc, Wallingford, CT, 2005).